These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6189571)

  • 21. [Studies on the clinical effect of NK 631 for oral-cavity cancers (author's transl)].
    Ohashi Y; Abe M; Saito K; Mizutani H; Onishi S; Ueda N
    Jpn J Antibiot; 1979 Feb; 32(2):259-64. PubMed ID: 86622
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of sequential administration of bleomycin in combination with mitomycin C on squamous cell carcinoma of oral regions.
    Shingaki S; Kawasaki T; Nagamine T; Kanamaru T; Yokobayashi T; Nakajima T
    J Oral Surg; 1980 Dec; 38(12):886-92. PubMed ID: 6160232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of bleomycin in patients with incurable carcinoma of the oral cavity].
    Fries R; Wilfert KH
    Osterr Z Erforsch Bekampf Krebskr; 1973; 28(1):29-32. PubMed ID: 4123658
    [No Abstract]   [Full Text] [Related]  

  • 24. [Formation of giant cells in oral squamous cell carcinoma during bleomycin treatment: enzymehistochemical, electronmicroscopic and ultrahistochemical investigations (author's transl)].
    Burkhardt A; Bommer G; Gebbers JO; Höltje WJ
    Virchows Arch A Pathol Anat Histol; 1976 Feb; 369(3):197-214. PubMed ID: 56803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined therapy of oral cancer bleomycin and radiation: a clinical trial.
    Shanta V; Krishnamurthi S
    Clin Radiol; 1977 Jul; 28(4):427-9. PubMed ID: 68844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
    Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
    Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion.
    Shimizu S; Miyazaki A; Sonoda T; Koike K; Ogi K; Kobayashi JI; Kaneko T; Igarashi T; Ueda M; Dehari H; Miyakawa A; Hasegawa T; Hiratsuka H
    PLoS One; 2018; 13(4):e0195451. PubMed ID: 29672550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The problem of the perioperative chemotherapy of the squamous epithelial carcinoma of the mouth].
    Schmidseder R; Müller WE
    Schweiz Med Wochenschr; 1978 Jun; 108(24):915-9. PubMed ID: 78521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging and computed tomography in the assessment of mandibular invasion by squamous cell carcinoma of the oral cavity. Influence on surgical management and post-operative course.
    Farrow ES; Boulanger T; Wojcik T; Lemaire AS; Raoul G; Julieron M
    Rev Stomatol Chir Maxillofac Chir Orale; 2016 Nov; 117(5):311-321. PubMed ID: 27373806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of bleomycin combination in radiation therapy of squamous cell carcinoma of the oral cavity].
    Masaki N
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1725-30. PubMed ID: 2425746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MTX-BLM therapy for squamous cell carcinoma of the oral cavity].
    Yamamoto E; Kohama G; Kumagai S; Chujyo H; Sonoda A
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2496-501. PubMed ID: 6210051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preoperative application of NK 631 for carcinoma of oral cavity (author's transl)].
    Yamamoto E; Sunakawa H; Kohama GI
    Jpn J Antibiot; 1979 Feb; 32(2):253-8. PubMed ID: 86621
    [No Abstract]   [Full Text] [Related]  

  • 33. [The position of bleomycin in the treatment of malignant tumors in oral surgery - a critical analysis after 7 years of application (author's transl)].
    Schubert J; Wagner U
    Zahn Mund Kieferheilkd Zentralbl; 1981; 69(4):227-32. PubMed ID: 6170190
    [No Abstract]   [Full Text] [Related]  

  • 34. Superselective intra-arterial infusion chemotherapy for stage III/IV squamous cell carcinomas of the oral cavity: midterm results.
    Ikushima I; Korogi Y; Ishii A; Hirai T; Yamura M; Nishimura R; Baba Y; Yamashita Y; Shinohara M
    Eur J Radiol; 2008 Apr; 66(1):7-12. PubMed ID: 17604932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clinical and histopathological study of anticancer effect of treatment with bleomycin alone--with particular reference to histological disappearance of primary lesion].
    Amagasa T; Shioda S; Iwaki H; Yokoo E; Sato K; Fujii E; Hasegawa K; Okada N; Michi K; Shimizu M
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):106-13. PubMed ID: 2582071
    [No Abstract]   [Full Text] [Related]  

  • 36. [Initial results of cytostatic therapy of squamous cell carcinoma of the oral cavity using a combination of methotrexate and bleomycin].
    Bitter K
    Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1973 Feb; 60(2):81-93. PubMed ID: 4122694
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinico-pathological features of squamous cell carcinoma of the oral cavity in patients <40 years of age.
    Sasaki T; Moles DR; Imai Y; Speight PM
    J Oral Pathol Med; 2005 Mar; 34(3):129-33. PubMed ID: 15689225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastases following biopsy of oral carcinoma in hamsters and the role of local prebiopsy bleomycin.
    Rallis G; Mourouzis C; Papakosta V; Donta I; Perrea D; Patsouris E; Vairaktaris E
    Anticancer Res; 2008; 28(4B):2253-7. PubMed ID: 18751403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse mode of tumor cell invasion and expression of mutant p53 protein but not of p21 protein are correlated with treatment failure in oral carcinomas and their metastatic foci.
    Osaki T; Kimura T; Tatemoto Y; Dapeng L; Yoneda K; Yamamoto T
    Oncology; 2000 Jun; 59(1):36-43. PubMed ID: 10895065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical effects of NK 631, a new bleomycin derivative, in treatment of oral cancer (author's transl)].
    Kajiyama M; Dohjyo M; Ohno A; Nagasaka K; Yamaguma M; Okabe T; Terasaka S
    Jpn J Antibiot; 1979 Jan; 32(1):129-37. PubMed ID: 84883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.